RhumbLine Advisers’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,000	Closed	-$5.9K	–	4326
2023 Q3	$5.9K	Hold	9,000	–	–	﹤0.01%	3951
2023 Q2	$3.6K	Buy	+9,000	New	+$3.6K	﹤0.01%	4135